Roche sales up 5 percent amid rush for Tamiflu, cancer drugs
Swiss drug giant Roche said Thursday that heightened demand for its Tamiflu drug amid a severe flu season, as well as for its cancer medicines had sent its first-quarter sales up five percent, beating analyst expectations.
Apr 11, 2013